Search Results - "SHUSTERMAN, N. H"

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure by Packer, Milton, Bristow, Michael R, Cohn, Jay N, Colucci, Wilson S, Fowler, Michael B, Gilbert, Edward M, Shusterman, Neil H

“…Activation of the sympathetic nervous system is one of the cardinal pathophysiologic abnormalities in patients with chronic heart failure. Levels of…”
Get full text

The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency by Gehr, T W, Tenero, D M, Boyle, D A, Qian, Y, Sica, D A, Shusterman, N H

“…Carvedilol, a chiral compound possessing nonselective beta- and alpha1-blocking activity, is used for the treatment of hypertension and congestive heart…”
Get full text

Safety and efficacy of eprosartan, a new angiotensin II receptor blocker by Shusterman, Neil H.

“…Angiotensin-converting enzyme inhibitors have been used extensively in the management of hypertension and related cardiovascular conditions. However, this…”
Get full text

The PRESTO (Prevention of Restenosis with Tranilast and its Outcomes) protocol: A double-blind, placebo-controlled trial by Holmes, David, Fitzgerald, Peter, Goldberg, Sheldon, LaBlanche, J-M, Lincoff, A.Michael, Savage, Michael, Serruys, P.W., Willerson, James, Granett, Jeffrey R., Chan, Robert, Shusterman, Neil H., Poland, Marcia

“…Background Tranilast is a unique drug in clinical development for the prevention of restenosis after percutaneous transluminal coronary revascularization…”
Get full text

Successful use of double-lumen, silicone rubber catheters for permanent hemodialysis access by Shusterman, Neil H., Kloss, Kathleen, Mullen, James L.

Get full text

What is the cost of nephrotoxicity associated with aminoglycosides? by Eisenberg, J M, Koffer, H, Glick, H A, Connell, M L, Loss, L E, Talbot, G H, Shusterman, N H, Strom, B L

“…We measured the economic impact of aminoglycoside-associated nephrotoxicity in a nested case-control study at six Philadelphia area hospitals. From the charts…”
Get more information

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial by PACKER, M, COLUCCI, W. S, GOTTLIEB, S. S, PEARLE, D, CODY, R. J, GREGORY, J. J, KANTROWITZ, N. E, LEJEMTEL, T. H, YOUNG, S. T, LUKAS, M. A, SHUSTERMAN, N. H, SACKNER-BERNSTEIN, J. D, LIANG, C.-S, GOLDSCHER, D. A, FREEMAN, I, KUKIN, M. L, KINHAL, V, UDELSON, J. E, KLAPHOLZ, M

“…Background Carvedilol has improved the symptomatic status of patients with moderate to severe heart failure in single-center studies, but its clinical effects…”
Get full text

Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: Retrospective analysis of the US Carvedilol Heart Failure Trials Program by Joglar, Jose A., Acusta, Andre P., Shusterman, Neil H., Ramaswamy, Karthik, Kowal, Robert C., Barbera, Saverio J., Hamdan, Mohamed H., Page, Richard L.

“…Background Atrial fibrillation (AF) is present in a significant number of patients with congestive heart failure (CHF) caused by left ventricular dysfunction…”
Get full text

Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure by Piltz, J R, Stone, R A, Boike, S, Everitt, D E, Shusterman, N H, Audet, P, Zariffa, N, Jorkasky, D K

“…Recent studies have suggested that intravenous infusion of fenoldopam, a selective dopamine-1 receptor agonist, elevates intraocular pressure (IOP) in man…”
Get more information

Management of refractory peritonitis to maintain the peritoneum for subsequent dialysis by Shusterman, N H, Jacobs, J

“…Peritonitis and its sequelae remain major clinical problems in treating peritoneal dialysis (PD) patients. One of these sequelae is the formation of…”
Get more information

Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function by Shusterman, N H, Elliott, W J, White, W B

“…Patients with hypertensive crises often experience reduced renal function that may worsen as the elevated blood pressure is treated. Fenoldopam, a novel,…”
Get more information

Controlled study of renal osteodystrophy in patients undergoing dialysis. Improved response to continuous ambulatory peritoneal dialysis compared with hemodialysis by Shusterman, N H, Wasserstein, A G, Morrison, G, Audet, P, Fallon, M D, Kaplan, F

“…To assess the effect of different dialysis modalities on renal osteodystrophy, a controlled study was performed in six patients undergoing continuous…”
Get more information

Fatal massive hepatic necrosis in cytomegalovirus mononucleosis by Shusterman, N H, Frauenhoffer, C, Kinsey, M D

Get more information

Treatment of anxiety: phenobarbital versus the benzodiazepines by Shusterman, N H

Get more information

Reprocessing of hemodialyzers: a critical appraisal by Shusterman, N H, Feldman, H I, Wasserstein, A, Strom, B L

“…The reprocessing of hemodialysis equipment was originally developed to conserve scarce resources and to reduce the time necessary to construct early dialyzers…”
Get more information

Safety and efficacy of eprosartan, a new angiotensin II receptor blocker: Challenging the Paradigm for Treatment of Hypertension: Focus on Elevated Systolic Blood Pressure by SHUSTERMAN, N. H

Get full text

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group by Packer, M, Bristow, M R, Cohn, J N, Colucci, W S, Fowler, M B, Gilbert, E M, Shusterman, N H

“…Controlled clinical trials have shown that beta-blockers can produce hemodynamic and symptomatic improvement in chronic heart failure, but the effect of these…”
Get full text

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise by Packer, M, Colucci, W S, Sackner-Bernstein, J D, Liang, C S, Goldscher, D A, Freeman, I, Kukin, M L, Kinhal, V, Udelson, J E, Klapholz, M, Gottlieb, S S, Pearle, D, Cody, R J, Gregory, J J, Kantrowitz, N E, LeJemtel, T H, Young, S T, Lukas, M A, Shusterman, N H

“…Carvedilol has improved the symptomatic status of patients with moderate to severe heart failure in single-center studies, but its clinical effects have not…”
Get full text